Shanghai Fosun Pharmaceutical (Group) Co Financial Overview
Shanghai Fosun Pharmaceutical (Group) Co's market cap is currently $9.58B. The company's EPS TTM is $0.044106179999999995; its P/E ratio is 15.36; and it has a dividend yield of 1.76%. Shanghai Fosun Pharmaceutical (Group) Co is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
